Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
RESEARCH TOOLSreports
Holding BCLI?
Track your performance easily
Technical Sentiment
Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 1.98, while Brainstorm Cell Therapeutics’s (BCLI) share price is $2.37, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 2.04, while Brainstorm Cell Therapeutics’s (BCLI) share price is $2.37, making it a Buy.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
2.21
2.28
2.36
2.43
2.51
2.58
2.66
Fibonacci
2.28
2.33
2.37
2.43
2.48
2.52
2.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
2.32Buy
2.33Buy
MA10
2.16Buy
2.17Buy
MA20
1.87Buy
1.98Buy
MA50
1.72Buy
2.04Buy
MA100
2.75Sell
2.73Sell
MA200
4.83Sell
4.11Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 2.17, while Brainstorm Cell Therapeutics’s (BCLI) share price is $2.37, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 2.73, while Brainstorm Cell Therapeutics’s (BCLI) share price is $2.37, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $2.37 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 1.72, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $2.37 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 2.75, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $2.37 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 4.83, creating a Sell signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
63.49
Neutral
STOCH (9,6)
93.46
Sell
STOCHRSI (14)
93.83
Sell
MACD (12,26)
0.20
Sell
ADX (14)
27.35
Neutral
Williams %R
-12.04
Sell
CCI (14)
98.61
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
63.22
Neutral
ROC
50.00
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 63.49, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 27.35, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 98.61, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 50.00, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Hold.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 63.49, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is 0.20, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 2.32, which suggests BCLI is a Buy.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 1.87, which suggests BCLI is a Buy.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 1.72, which suggests BCLI is a Buy.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 4.83, which suggests BCLI is a Sell.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -12.04, which suggests BCLI is a Sell.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 98.61, which suggests BCLI is a Neutral.